+1-888-308-5802      . .

Moderna’s new bivalent booster stand strong against Omicron subvariants

Author : Pankaj Singh | Published Date : 2022-06-24 

Moderna’s new bivalent booster stand strong against Omicron subvariants

As per reliable sources, Moderna Inc. announced that its modified COVID-19 vaccine induces a potent immune response against the Omicron subvariants BA.4 and BA.5 which have recently spread throughout the United States.

Additionally, the biotech major expressed optimism that its bivalent vaccine, which is intended to combat two different variants of COVID-19, will be approved as a booster shot in the U.S. soon. the vaccine is designed to counter both the original Coronavirus variant of 2020 and the Omicron strain from the last winter.

As per the results from the latest clinical trial, the booster shot elicited a lesser reaction against the omicron variants BA.4 and BA.5 than it does against the BA.1. Additionally, the new injection may provide durable protection against the whole family of Omicron variants.

It is worth mentioning here that before receiving regulatory permissions, the pharmaceutical behemoth has begun producing the new COVID-19 vaccine at its own expense. According to CEO Stephane Bancel of Moderna, the booster shot might start dispensing in the U.S. in August this year.

Meanwhile, in the upcoming weeks, the company aims to approach regulators for permission to use the shot, which it refers to as mRNA-1273.214, for the fall season.

More than a third of cases in the United States last week was attributed to the two sublineages, which were classified as variants of concern by the European Centre for Disease Prevention and Control as well as added to the WHO's monitoring list in March.

The U.S. Food and Drug Administration is soon planning a meeting with independent specialists to discuss the optimum formulation of booster injections before the official launch.

Additionally, Pfizer and BioNTech are evaluating several potential COVID-19 variant-adapted vaccines, including a bivalent contender that is comparable to Moderna's. Although the businesses have not yet provided any information on the efficacy of their products, the European Medicines Agency however has begun the examination of their prospects.

Source Credit:

https://health.economictimes.indiatimes.com/news/pharma/moderna-booster-candidate-shows-strong-response-against-omicron-subvariants/92391968

About Author

Pankaj Singh . .

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

IKEA U.S. joins Electrify America for fast charging at 25+ IKEA stores

IKEA U.S. joins Electrify America for fast charging at 25+ IKEA stores

Published Date: 2022-08-12         Author: Pankaj Singh

IKEA U.S. has reportedly announced that it will collaborate with Electrify Commercial and Electrify America to add ultra-fast charging stations and delivery fleet EV charging to more than 25 IKEA retail locations in the U.S. This collaboration will help IKEA to be a climate-positive business by 2... Read More>>

BeautyHealth & Innerskin unite to bring HydraFacial to Galeries Lafayette

BeautyHealth & Innerskin unite to bring HydraFacial to Galeries Lafayette

Published Date: 2022-08-10         Author: Pankaj Singh

BeautyHealth, a global category-creating company, has recently announced that its leading brand Hydrafacial is set to enter the brand-new wellness floor at Galeries Lafayette Haussmann, a true Paris institution, in collaboration with Innerskin, a firm specializing in premium skincare products. Re... Read More>>

Geek+ secures $100M in series E1 funding from Intel & other investors

Geek+ secures $100M in series E1 funding from Intel & other investors

Published Date: 2022-08-09         Author: Pankaj Singh

Geek+, a global technology company specializing in smart logistics, has recently raised $100 million in a series E1 funding round from Intel Capital, Qingyue Capital Investment, and Vertex Growth, bringing the firm’s valuation to around $2 billion. According to the company, this funding wil... Read More>>

© 2022 Fractovia. All Rights Reserved